T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsWěi Li, Gerald Schmid‐Bindert, Cao Zhao et al.|Lung Cancer|2014Cited by 94
Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell linesH Li, Caicun Zhou, Gerald Schmid‐Bindert et al.|Advances in Medical Sciences|2011Cited by 85
Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring systemGerald Schmid‐Bindert, Lothar R. Pilz, Caicun Zhou et al.|Respirology|2012Cited by 66